ClinConnect ClinConnect Logo
Search / Trial NCT06502028

Video Laryngeal Mask Versus Endotracheal Tube Undergoing Laparoscopic Cholecystectomy Surgery

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jul 8, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two methods of managing the airway during laparoscopic cholecystectomy surgery, which is a procedure to remove the gallbladder. Specifically, the trial is comparing the use of a video laryngeal mask, a device that helps keep the airway open, with a traditional endotracheal tube, which is a tube inserted into the windpipe. The goal is to see which method is more effective and safer for patients undergoing this type of surgery.

To participate in this trial, you need to be at least 19 years old and scheduled for an elective laparoscopic cholecystectomy. However, certain conditions may exclude you, such as a high risk of choking, difficulties with your airway, obesity, or loose teeth. If you qualify and choose to participate, you will help researchers understand the best way to manage the airway during surgery, which could lead to better outcomes for patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients over 19 years old
  • Patients planned for elective laparoscopic cholecystectomy
  • Exclusion Criteria:
  • High risk of aspiration (e.g. gastro-esophageal reflux disease, hiatus hernia, pregnancy, history of gastrectomy)
  • Difficult airway (e.g. limitation of mouth opening, limitation of neck extension, oropharyngeal pathology)
  • Obesity (BMI \> 30 kg/m2)
  • Tooth mobility

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Hansol KIM, MD

Principal Investigator

Seoul National University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported